Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection

Journal of Virology

Volumn 86, Issue 2, 2012, Pages 1010-1020

  Fang, Jiali ^a,b   Hao, Qian ^a   Liu, Li ^a   Li, Yongkui ^a   Wu, Jianguo ^a   Huo, Xixiang ^c   Zhu, Ying ^a  

^a WUHAN UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 29; MICRORNA; MICRORNA 29; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EPIGENETICS; FEMALE; HUMAN; HUMAN CELL; INFLUENZA A; INFLUENZA VIRUS A H3N2; LUNG ALVEOLUS EPITHELIUM; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION;

ADULT; ANIMALS; CELL LINE; CHICK EMBRYO; COHORT STUDIES; CYCLOOXYGENASE 2; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EPIGENESIS, GENETIC; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; INTERLEUKINS; MALE; MICRORNAS; MIDDLE AGED; TRANSCRIPTIONAL ACTIVATION; YOUNG ADULT;

INFLUENZA A VIRUS;

EID: 84863155016     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06169-11     Document Type: Article

References (48)

1. Angeli V, et al. 2004. Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. J. Immunol. 172:3822-3829.
2. Asahi-Ozaki Y, et al. 2006. Intranasal administration of adjuvantcombined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection. Microbes Infect. 8:2706-2714.
3. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. Microbiol. 116:281-297.
4. Betz M, Fox BS. 1991. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146:108-113.
5. Campbell PM, Syzf M. 2003. Human DNA methyltransferase gene DNMT1 is regulated by the APC pathway. Carcinogenesis 24:17-24.
6. Carey MA, et al. 2003. Accentuated T helper type 2 airway response after allergen challenge in cyclooxygenase-1-/- but not cyclooxygenase-2-/-mice. Am. J. Respir. Crit. Care Med. 167:1509-1515.
7. Chen N, Restivo A, Reiss CS. 2002. Selective inhibition of COX-2 is beneficial to mice infected intranasally with VSV. Prostaglandins Other Lipid Mediat. 67:143-155.
8. Chen T, Li E. 2004. Structure and function of eukaryotic DNA methyltransferases. Curr. Top. Dev. Biol. 60:55-89.
9. de Maat MFG, et al. 2007. Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer. J. Clin. Oncol. 25:4887-4894.
10. Ejima K, et al. 2003. Cyclooxygenase- 2-deficient mice are resistant to endotoxin-induced inflammation and death. FASEB J. 17:1325-1327.
11. Fabbri M, et al. 2007. MicroRNA-29 family reverts aberrant methylation in lung cancer by targetingDNAmethyltransferases 3A and 3B. Proc. Natl. Acad. Sci. U. S. A. 104:15805-15810.
12. Garzon R, et al. 2009. MicroRNA 29b functions in acute myeloid leukemia. Blood 114:5331-5341.
13. Hanson JA, et al. 2006. Gene promoter methylation in prostate tumorassociated stromal cells. J. Natl. Cancer Inst. 98:255-261.
14. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. 1996. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U. S. A. 93:9821-9826.
15. Hui KP, et al. 2009. Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK. J. Immunol. 182:1088-1098.
16. Kotenko SV, et al. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptorcomplex. Nat. Immunol. 4:69-77.
17. Lee JO, Jung KHJK, Choi KH, Min DS, Jang KL. 2005. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase. Oncogene 24:6617-6625.
18. Li H, Chen RTZX, Szabó PE, Riggs AD, Pfeifer GP. 2006. The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells. J. Biol. Chem. 281:19489-19500.
19. Li W, et al. 2009. Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection. Eur. J. Immunol. 39:1019-1024.
20. Li W, et al. 2008. Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLoS One 3:e1985.
21. Ludwig S, Pleschka S, Planz O, Wolff T. 2006. Ringing the alarm bells: signalling and apoptosisin influenza virus infected cells. Cell. Microbiol. 8:375-386.
22. Luttmann W, et al. 1999. Modulation of cytokine release from mononuclear cells by prostacyclin, IL-4 and IL-13. Cytokine 11:127-133.
23. Maggi LB, Jr, et al. 2002. Novel role for calcium-independent phospholipase A(2) in the macrophage antiviral response of inducible nitric-oxide synthase expression. J. Biol. Chem. 277:38449-38455.
24. Martin JG, et al. 2002. The immunomodulatory actions of prostaglandin E2 on allergic airway responses in the rat. J. Immunol. 169:3963-3969.
25. Martinson BD, Corbett ACJA, Wysolmerski RB, Ford DA. 2003. Calcium-independent phospholipase A2 mediates CREB phosphorylation in double-stranded RNA-stimulated endothelial cells. J. Lipid Res. 44:1686-1691.
26. Misra UK, Pizzo SV. 2005. Coordinate regulation of forskolin-induced cellular proliferation in macrophages by protein kinase A/cAMP-response element-binding protein (CREB) and Epac1-Rap1 signaling: effects of silencing CREB gene expression on Akt activation. J. Biol. Chem. 280: 38276-38289.
27. Mizumura K, et al. 2003. Role of mitogen-activated protein kinases in influenza virus induction of prostaglandin E2 from arachidonic acid in bronchial epithelial cells. Clin. Exp. Allergy 33:1244-1251.
28. Mott JL, Bronk KSSF, Gores GJ. 2007. Mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26:6133-6140.
29. Noguchi K, Endo H, Kondo H, Ishikawa I. 2001. Prostaglandin E2 upregulates interleukin-6 production in human gingival fibroblasts. J. Periodontal Res. 36:80-87.
30. Osterlund P, et al. 2005. Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J. Virol. 79:9608-9617.
31. Osterlund PI, Pietila TE, Veckman V, Kotenko SV, Julkunen I. 2007. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-λ) genes. J. Immunol. 179:3434-3442.
32. Park IY, et al. 2007. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 132: 1476-1494.
33. Reddy RC, et al. 2001. Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis. Am. J. Physiol. 281:L537-L543.
34. Rintahaka J, Kovanen WDPE, Alenius H, Matikainen S. 2008. Cytosolic antiviralRNArecognition pathway activates caspases 1 and 3. J. Immunol. 180:1749-1757.
35. Scarfì S, et al. 2007. Ascorbic acid-pretreated quartz enhances cyclooxygenase-2 expression in RAW 264.7 murine macrophages. FEBS J. 274: 60-73.
36. Sheppard P, et al. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4:63-68.
37. Sirén J, Pirhonen J, Julkunen I, Matikainen S. 2005. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL- J. Immunol. 174:1932-1937.
38. Stohr K. 2005. Avian influenza and pandemics-research needs and opportunities. N. Engl. J. Med. 352:405-407.
39. Szyf M. 2002 Utilization of antisense oligonucleotides to study the role of 5-cytosine DNA methyltransferase in cellular transformation and oncogenesis. Methods 27:184-191.40
40. Thomson SJP, et al. 2009. The role of transposable elements in the regulation of IFN-λ1 gene expression. Proc. Natl. Acad. Sci. U. S. A. 106: 11564-11569.
41. Traynor TR, Bohnet MJSG, Krueger JM. 2004. Intratracheal doublestranded RNA plus interferon-gamma: a model for analysis of the acute phase response to respiratory viral infections. Life Sci. 74:2563-2576.
42. Tumpey TM, et al. 2005. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310:77-80.
43. Volinia S, et al. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103: 2257-2261.
44. Wang J, et al. 2009. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J. Immunol. 182:1296-1304.
45. Xie ZH, et al. 2006. Mutations in DNA methyltransferase DNMT3B in ICF syndrome affect its regulation by DNMT3L. Hum. Mol. Genet. 15: 1375-1385.
46. Xiong Y, et al. 2010. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51:836-845.
47. Yanaihara N, et al. 2006. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189-198.
48. Zheng DL, et al. 2009. Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. J. Hepatol. 50:377-387.